Proteomics is a rapidly expanding discipline that aims to gain a comprehensive understanding of the expressions, modification, interactions, and regulation of proteins in cells. New high-throughput technologies, such as protein chips and isotope-coded affinity tag peptide labeling, coupled with classic technologies such as two-dimensional gel electrophoresis and mass spectrometry, complement genomic technologies, providing cancer researchers with powerful tools for cancer diagnosis and prognosis and for the identification of targets for therapy.
References
1.
BabaY.Development of novel biomedicine based on genome science. Eur. J. Pharm. Sci.13, 3–4 (2001).
2.
BaillieL., ReadT. D.Bacillus anthracis, a bug with attitude!. Curr. Opin. Microbiol.4, 78–91 (2001).
3.
AnderssonS. G., ZomorodipourA., AnderssonJ. O., Sicheritz-PontenT., AlsmarkU. C., PodowskiR. M., NaslundA. K., ErikssonA. S., WinklerH. H., KurlandC. G.The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature (Land.)396, 133–140 (1998).
4.
PangC. P., BaumL., LamD. S.Hunting for disease genes in multifunctional diseases. Clin. Chem. Lab. Med.38, 819–825 (2000).
5.
YanagidaM.Functional proteomics; current achievements. J. Chramatagr. B Analyt. Technal. Biamed. Life. Sci771, 89–106 (2002).
6.
PandeyA., MannM.Proteomics to study genes and genomes. Nature405, 837–846 (2000).
7.
BaggerlyK. A., CoombesK. R., HessK. R., StiversD. N., AbruzzoL. V., ZhangW.Identifying differentially expressed genes in cDNA microarray experiments. J. Camput. Biol.8, 639–659(2001).
ChenX., CheungS. T., SoS., FanS. T., BarryC., HigginsJ., LaiK. M., JiJ., DudoitS., NgI. O., Van De RijnM., BotsteinD., BrownP. O.Gene expression patterns in human liver cancers. Mol. Biol. Cell6, 1929–1939 (2002).
10.
NielsenT. O., WestR. B., LinnS. C., AlterO., KnowlingM. A., O'ConnellJ. X., ZhuS., FeroM., SherlockG., PollackJ. R., BrownP. O., BotsteinD., van de RijnM.Molecular characterisation of soft tissue tumours: A gene expression study. Lancet359, 1301–7 (2002).
11.
RossD. T., ScherfU., EisenM. B., PerouC. M., ReesC., SpellmanP., IyerV., JeffreyS. S., Van de RijnM., WalthamM., PergamenschikovA., LeeJ. C., LashkariD., ShalonD., MyersT. G., WeinsteinJ. N., BotsteinD., BrownP. O.Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet.24, 227–35 (2000).
12.
KhanJ., WeiJ. S., RingnerM., SaalL. H., LadanyiM., WestermannF., BertholdF., SchwabM., AntonescuC. R., PetersonC., MeltzerP. S.Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med.7, 673–679 (2001).
13.
ZhangW., LabordeP. M., CoombesK. R., BerryD. A., HamiltonS. R.Cancer genomics: Promises and complexities. Clin. Cancer Res.7, 2159–2167 (2001).
14.
CaskeyL. S., FullerG. N., BrunerJ. M., YungW. K., SawayaR. E., HollandE. C., ZhangW.Toward a molecular classification of the gliomas: Histopathology, molecular genetics, and gene expression profiling. Histol. Histopathol.15, 971–981 (2000).
15.
MeltzerP. S.Spotting the target: Microarrays for disease gene discovery. Curr. Opin. Genet. Dev.11, 258–263 (2001).
16.
AlizadehA., EisenM., BotsteinD., BrownP. O., StaudtL. M.Probing lymphocyte biology by genomic-scale gene expression analysis. J. Clin. Immunol.18, 373–379 (1998).
17.
WhitfieldM. L., SherlockG., SaldanhaA. J., MurrayJ. I., BallC. A., AlexanderK. E., MateseJ. C., PerouC. M., HurtM. M., BrownP. O., BotsteinD.Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell13, 1977–2000 (2002).
18.
BrownP. O., BotsteinD.Exploring the new world of the genome with DNA microarrays. Nat. Genet.21, 33–7 (1999).
19.
GygiS. P., RochonY., FranzaB. R., AebersoldR.Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol.19, 1720–1730 (1999).
20.
DoveA.Proteomics: Translating genomics into products?Nat. Biotechnol.17, 233–236 (1999).
FieldsS.Proteomics in genomeland. Science291, 1221–1224 (2001).
23.
WilkinsonD.Pursuing Proteomes. The Scientist14, 28–33 (2000).
24.
JabburJ. R., HuangP., ZhangW.DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in viva. Oncogene19, 6203–6208 (2000).
25.
ZhongX., SchneiderT. J., CabralD. S., DonohoeT. J., RothsteinT. L.An alternatively spliced long form of Fas apoptosis inhibitory molecule (FAIM) with tissue-specific expression in the brain. Mol. Immunol.38, 65–72 (2001).
26.
CascinoI., FiucciG., PapoffG., RubertiG.Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol.154, 2706–2713 (1995).
27.
BormanS.Proteomics: Taking over where genomics leaves off. Chemical & Engineering News78, 31–37 (2000).
28.
WulfkuhleJ. D., McLeanK. C., PaweletzC. P., SgroiD. C., TrockB. J., SteegP. S., PetricoinE. F.IIINew approaches to proteomic analysis of breast caner. Proteomics1, 1205–1215 (2001).
29.
BallG., MianS., HoldingF., AlliboneR. O., LoweJ., AliS., LiG., McCardleS., EllisI. O., CreaserC., ReesR. C.An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics18, 395–404 (2002).
30.
EggelingF., JunkerK., FiedlerW., WollscheidV., DürstM., ClaussenU., ErnstG.Mass spectrometry meets chip technology: A new proteomic tool in cancer research?Electrophoresis22, 2898–2902 (2001).
31.
PetricoinE. F., ArdekaniA., HittB., HackettP., OrnsteinD., VelascoA., TruccoC., PaweletzC., Emmert-BuckM., KohnE., TrostR., MillsG., FishmanD., LiottaL.A learning algorithm diagnosis prostate and ovarian cancer from human serum based on multiparametric proteomic patterns. Proc. Am. Assoc. Cancer. Res.42, 285 (2001).
32.
PetricoinE. F., ArdekaniA. M., HittB. A., LevineP. J., FusaroV. A., SteinbergS. M., MillsG. B., SimoneC., FishmanD. A., KohnE. C., LiottaL. A.Use of proteomic patterns in serum to identify ovarian cancer. Lancet359, 572–577 (2002).
33.
WuY., SzaroR., MatczakE., ZowczakB., TorlinskiL., WatkinsB.Detection of serum breast cancer markers by mass spectrometry. Proc. Am. Assoc. Cancer. Res.42, 10 (2001).
34.
VlahouA., SchellhammerP. F., MendrinosS., PatelK., KondylisF. I., GongL., NasimS., WrightG. L.Jr. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol.158, 1491–1502 (2001).
35.
RostyC., ChristaL., KuzdzalS., BaldwinW. M., ZahurakM. L., CarnotF, ChanD. W., CantoM., LillemoeK. D., CameronJ. L., YeoC. J., HrubanR. H., GogginsM.Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res.62, 1868–1875 (2002).
36.
BorrebaeckC. A.K. Antibodies in diagnostics-from immunoassays to protein chips. Immunology Today21, 379–382 (2000).
37.
WildtR. M.T., Mundy, C. R., Gorick, B. D., Tomlinson, I. M. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat. Biotechnol.18, 989–994, (2000).
38.
HuangR.Detection of multiple proteins in an antibody-based protein microarray system. J. Immunological Methods255, 1–13 (2001).
39.
SreekumarA., NyatiM. K., VaramballyS., BarretteT. R., GhoshD., LawrenceT. S., ChinnaiyanA. M.Profiling of cancer cells using protein microarrays: Discovery of novel radiation-regulated proteins. Cancer Res.61, 7585–7593 (2001).
40.
HuangR., LinY., WangC. C., GanoJ., LinB., ShiQ., BoyntonA., BurkeJ., HuangR. P.Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res.62, 2806–2812 (2002).
41.
GeH.UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Res.28, 2E3–e3 (2000).
42.
ArenkovP., KukhtinA., GemmellA., VoloshchukS., ChupeevaV., MirzabekovA.Protein microchips: Use for immunoassay and enzymatic reactions. Anal Biochem.278, 123–131 (2000).
43.
KloseJ.Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutation in mammals. Human Genetik26, 231–243 (1975).
44.
O'FarrellP. H.High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem.250, 4007–4021 (1975).
45.
AppelR. D., BairochA., HochstrasserD. F., A new generation of information retrieval tools for biologists: The example of the ExPASy WWW server. TIBS19, 258–260 (1994).
46.
HochstrasserD. F., AppelR. D., GolazO., PasqualiC., SanchezJ., BairochA.Sharing of world wide spread knowledge using hypermedia facilities and fast communication protocols (mosaic and world wide web): The example of ExPASy. Methods Inf. Med.34, 75–78 (1995).
47.
LiberatoriS., BiniL., De FeliceC., MagiB., MarzocchiB., RaggiaschiR., FrutigerS., SanchezJ. C., WilkinsM. R., HughesG., HochstrasserD. F., BracciR., PalliniV.A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation. Electrophoresis18, 2816–2822 (1997).
48.
CelisJ. E., OstergaardM., RasmussenH. H., GromovP., GromovaI., VarmarkH., PalsdottirH., MagnussonN., AndersenI., BasseB., LauridsenJ. B., RatzG., WolfH., OrntoftT. F., CelisP., CelisA.A comprehensive protein resources for the study of bladder cancer: http://biobase.dk/cgi-bin/celis. Electrophoresis20, 300–309 (1999).
49.
StulikJ., KoupilovaK., OsterreicherJ., KnizekJ., MacelaA., BuresJ., JandikP., LangrF., DedicK., JungblutP. R.Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis20, 3638–3646 (1999).
50.
RasmussenR. K., JiH., EddesJ. S., MoritzR. L., ReidG. E., SimpsonR. J.Database of protein from the human breast carcinoma cell line MDA-MB231. Electrophoresis18, 588–589 (1997).
51.
GygiS. P., CorthalsG. L., ZhangY., RochonY., AebersoldR.Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. USA97, 9390–9395 (2000).
52.
RabilloudT.Two-dimensional gel electrophoresis in proteomics: Old, old-fashioned, but still climbs up the mountains. Proteomics2, 3–10 (2002).
53.
CorthalsG. L., WasingerV. C., HochstrasserD. F., SanchezJ. C.The dynamic range of protein expression: A challenge for proteomic research. Electophoresis21, 1104–1115 (2000).
54.
WallinE., von HeijneG.Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci.7, 1029–1038 (1998).
55.
HenzelW. J., BilleciT. M., StultsJ. T., WongS. C.Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc. Natl. Acad. Sci. USA90, 5011–5015 (1993).
56.
MannM., WilmM.Error-Tolerant Identification of Peptides in Sequence Databases by Peptide Sequence Tags. Anal Chem.66, 4390–4399 (1994).
57.
PappinD. J. C., HojrupP., BleasbyA. J.Rapid identification of proteins by peptide-mass fingerprinting. Curr. Biol.3, 327–332 (1993).
58.
MannM., HojrupP., RoepstorffP.Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol. Mass Spectrom.22, 338–345 (1993).
59.
WilkinsM. R., GasteigerE., WheelerC. H., LindskogI., SanchezJ. C., BairochA., AppelR. D., DunnM. J., HochstrasserD. F.Multiple parameter cross-species protein identification using MultiIdent-a world-wide web accessible tool. Electrophoresis19, 3199–3206 (1998).
60.
WilkinsM., GasteigerE., TonellaL., OuK., TylerM., SanchezJ., GooleyA., WalshB., BairochA., AppelR., WilliamsK., HochstrasserD.Protein identification with N and C-terminal sequence tags in proteome projects. J. Mol. Biol.278, 599–608 (1998).
61.
MarshallA. G., HendricksonC. L., JacksonG. S.Fourier Transform Ion Cyclotron Resonance Mass Spectrometry: A Primer. Mass Spectrom Rev17, 1–35 (1998).
62.
JensonP. K., Pasa-TolicLjiljana, AndersonG. A., HornerJ. A., LiptonM. S., BruceJ. E., SmithR. D.Probing proteomes using capillary isoelectric focusing-electrospray ionization fourier transform ion cyclotron resonance mass spectrometry. Anal Chem.71, 2076–2084 (1999).
63.
AdamB. L., VlahouA., SemmesO. J., WrightG. L.Jr. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics1, 1264–1270 (2001).
64.
ShalhoubP., KernS., GirardS., BerettaL.Proteomic-based approach for the identification of tumor markers associated with hepatocellular carcinoma. Dis. Markers17, 217–223 (2001).
65.
Vercoutter-EdouartA. S., LemoineJ., Le BourhisX., LouisH., BoillyB., NurcombeV., RevillionF., PeyratJ. P., HondermarckH.Proteomic analysis reveals that 14-3-3 sigma is down-regulated in human breast cancer cells. Cancer Res.61, 76–80 (2001).
66.
JungblutP. R., Zimny-ArndtU., Zeindl-EberhartE., StulikJ., KoupilovaK., PleissnerK. P., OttoA., MullerE. C., Sokolowska-KohlerW., GrabherG., StofflerG.Proteomics in human disease: Cancer, heart and infectious diseases. Electrophoresis20, 2100–2110 (1999).
67.
HanashS., BrichoryF., BeerD.A proteomic approach to the identification of lung cancer markers. Dis. Markes17, 295–300 (2001).
68.
OhJ. M., BrichoryF., PuravsE., KuickR., WoodC., RouillardJ. M., TraJ., KardiaS., BeerD., HanashS.A database of protein expression in lung cancer. Proteomics1, 1303–1319 (2001).
69.
ChongB. E., LubmanD. M., MillerF. R., RosenspireA. J.Rapid screening of protein profiles of human breast cancer cell lines using non-porous reversed-phase high performance liquid chromatography separation with matrix-assisted laser desorption/ionization time-off-light mass spectral analysis. Rapid Commun Mass Spectrom13, 1808–1812 (1999).
70.
GygiS. P., HanD. K. M., GingrasA., SonebergN., AebersoldR.Protein analysis by mass spectrometry and sequence database searching: Tools for cancer research in the post-genomic era. Electrophoresis20, 310–319 (1999).
71.
ChenS. T., PanT. L., TsaiY. C., HuangC. M.Proteomics reveals protein profile changes in doxorubin-treated MCF-7 human breast cancer cells. Cancer Lett181, 95–107 (2002).
72.
GygiS. P., RistB., GerberS. A., TurecsekF., GelbM. H., AebersoldR.Quantitative analysis of complex protein mixtures using isotope coded affinity tags. Nat. Biotechnol.17, 994–999 (1999).
73.
AebersoldR., GygiS. P., GriffinT. J., HanD. K. M., YelleM. J.The isotope-coded affinity tag reagent method for quantitative proteomics. American Genomic Proteomic Technology1, 22–27 (2001).
74.
ZhouH., RanishJ. A., WattsJ. D., AebersoldR.Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry. Nat. Biotechnol.20, 512–515 (2002).
75.
MoseleyM. A.Current trend in differential expression proteomics: Isotopically coded tags. Trends in Biotech. 19, S10–S16 (2001).
76.
GosheM. B., ConradsT. P., PaniskoE. A., AngellN. H., VeenstraT. D., SmithR. D.Phosphoprotein Isotope-Coded Affinity Tag Approach for Isolating and Quantitating Phosphopeptides in Proteome-Wide Analyses. Anal Chem.73, 2578–2586 (2001).
77.
PawsonT., ScottJ. D.Signaling Through Scaffold, Anchoring, and Adaptor Proteins. Science278, 2075–2080 (1997).
78.
CohenP.The role of protein phosphorylation in neuraland hcw-monal control of cellular activity. Nature296, 613–20 (1982).
79.
TrepelM., ArapW., PasqualiniR.In viva phage display and vascular heterogeneity: implications for targeted medicine. Curr. Opin. Chem. Biol.6, 399–404 (2002).
80.
ArapW., PasqualiniR.The human vascular mapping project: Selection and utilization of molecules for tumor endothelial targeting. Haemastasis 31 Suppl1, 30–31 (2001).
SchramlP., KononenJ., BubendorfL., MochH., BissigH., NocitoA., MihatschM. J., KallioniemiO. P. and SauterG.Tissue microarrays for gene amplification surveys in many different tumor types. Clin. Cancer. Res.5, 1966–1975 (1999).
83.
KallioniemiO. P., WagnerU., KononenJ., SauterG.Tissue microarray technology for high-throughput molecular profiling of cancer. Hum. Mol. Genet.10, 657–662 (2001).
84.
WangH., WangH., ZhangW., FullerG. N.Tissue Microarrays: Applications in Neuropathology Research, Diagnosis, and Education. Brain Pathal.12, 95–107 (2002).
85.
HoosA., UristM. J., StojadinovicA., MastoridesS., DudasM. E., LeungD. H., KuoD., BrennanM. F., LewisJ. J., Cordon-CardoC.Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am. J. Pathal.158, 1245–1251 (2001).
86.
SallinenS. L., SallinenP. K., HaapasaloH. K., HelinH. J., HelenP. T., SchramlP., KallioniemiO. P., KononenJ.Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res.60, 6617–6622 (2000).
87.
BucherC., TorhorstJ., BubendorfL., SchramlP., KononenJ., MochH., MihatschM., KallioniemiO. P. and SauterG.Tissue microarrays (‘tissue chips’) for high-throughput cancer genetics: Linking molecular changes to clinical endpoints. Am. J. Hum. Genet.65, (suppl):A10 (1999).
88.
MucciN. R., AkdasG., ManelyS. and RubinM. A.Neuroendocrine expression in metastatic prostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum. Pathol.31, 406–U4 (2000).
89.
BucherC., TohorstJ., KononenJ., HaasP., AskaaJ., GodtfredsenS. E., BauerK. D., SeeligS., KallioniemiO. P. and SauterG.Automated, high-throughput tissue microarray analysis for assessing the significance of Her-2 involvement in breast cancer. J. Clin. Oncol. Annual Meeting2338 (2000).
90.
BarlundM., ForozanF., KononenJ., BubendorfL., ChenY., BittnerM. L., TorhorstJ., HaasP., BucherC., SauterG., KallioniemiO. P., KallioniemiA.Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J. Natl. Cancer Inst.92, 1252–1259 (2000).
91.
ZiauddinJ., SabatiniD. M.Microarrays of cells expressing defined cDNAs. Nature411, 107–110 (2001).
92.
FendF., RaffeldM.Laser capture microdissection in pathology. J. Clin. Pathol.53, 666–672 (2000).
93.
CravenR. A., BanksR. E.Laser capture microdissection and proteomics: Possibilities and limitation. Proteomics1, 1200–1204 (2001).
94.
AlevizosI., MahadevappaM., ZhangX., OhyamaH., KohnoY., PosnerM., GallagherG. T., VarvaresM., CohenD., KimD., KentR., DonoffR. B., ToddR., YungC. M., WarringtonJ. A., WongD. T.Oral cancer in viva gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncagene20, 6196–6204 (2001).
95.
GoldsworthyS. M., StocktonP. S., TrempusC. S., FoleyJ. F., MaronpotR. R.Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue. Mol. Carcinog.2, 86–91 (1999).
96.
YinY., LucianiM. G., FahraeusR.p53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nature Cell Biology4, 462–467 (2002).
97.
SimoneC., BagellaL., BellanC., GiordanoA.Physical interaction between pRB and cdk9/cyclinT2 complex. Oncogene21, 4158–4165 (2002).
98.
TongA. H. Y., DreesB., NardelliG., BaderG. D., BrannettiB., CastagnoliL., EvangelistaM., FerracutiS., NelsonB., PaoluziS.A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules. Science295, 321–324 (2002).
99.
ItoT., ChibaT., OzawaR., YoshidaM., HattoriM., SakakiY.A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. USA98, 4569–4574 (2001).
100.
ItoT., TashiroK., MutaS., OzawaR., ChibaT., NishizawaM., YamamotoK., KuharaS., SakakiY.Toward a protein-protein interaction map of the budding yeast: A comprehensive system to examine two-hybrid interactions in all possible combinations between the yeast proteins. Proc. Natl. Acad. Sci. USA97, 1143–1147 (2000).
101.
TuckerC. L., GeraJ. F., UetzP.Towards an understanding of complex protein networks. Trends in Cell Biology11, 102–106 (2001).
102.
SchwikowskiB., UetzP., FieldsS.A network of interacting proteins in yeast. Nature Biotechnol.18, 1257–1261 (2000).
103.
XenariosI., EisenbergD.Protein interaction databases. Current Opinion in Biotechnology12, 334–339 (2001).
104.
XenariosI., RiceD. W., SalwinskiL., BaronM. K., MarcotteE. M., EisenbergD.DIP: The database of interacting proteins. Nucleic Acids Res.28, 289–291 (2000).
105.
BaderG. D., HogueC. W.: BIND-a data specification for storing and describing biomolecular interactions, molecular complexes and pathways. Bioinformatics16, 465–477 (2000).
106.
UetzP., GiotL., CagneyG., MansfieldT. A., JudsonR. S., KnightJ. R., LockshonD., NarayanV., SrinivasanM., PochartP.: A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature403, 623–627 (2000).
107.
RainJ. C., SeligL., De ReuseH., BattagliaV., RverdyC., SimonS., LenzenG., PetelF., WojcikJ., SchachterV.: The protein-protein interaction map of Helicobacter pylori. Nature409, 211–215 (2001).
108.
XenariosI., FernandezE., SalwinskiL., DuanX. J., ThompsonM. J., MarcotteE. M., EisenbergD.: DIP: the database of interacting proteins: 2001 update. Nucleic Acids Res.29, 239–241 (2001).
MewesH. W., FrishmanD., GruberC., GeierB., HaaseD., KapsA., LemckeK., MannhauptG., PfeifferF., SchullerC.: MIPS: a database for genomes and protein sequences. Nuclei Acids Res.28, 37–40 (2000).
111.
CostanzoM. C., CrawfordM. E., HirschmanJ. E., KranzJ. E., OlsenP., RobertsonL. S., SkrzypekM. S., BraunB. R., HopkinsK. L., KonduP.: YPD, PombePD and WormPD: model organism volumes of the BioKnowledge library, an integrated resources for protein information. Nucleic Acids Res.29, 75–79 (2001).
